Zimmer Biomet Holdings, Inc.
ZBH
Classifica tra le azioni
#1249
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing... Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Prezzo delle azioni
$96.08
Capitalizzazione di mercato
$18.33B
Variazione (1 giorno)
1.06%
Variazione (1 anno)
-6.48%
Paese
US
Scambia Zimmer Biomet Holdings, Inc. (ZBH)
Categoria
Healthcare
Utile per Zimmer Biomet Holdings, Inc. (ZBH)
Utile nel Jun 2026 TTM: $933.60M
Secondo gli ultimi rapporti finanziari di Zimmer Biomet Holdings, Inc., gli utili attuali della società sono $933.60M. Nel 2024, la società ha registrato un utile di $1.04B, una diminuzione rispetto a agli utili del 2023, che erano di $1.07B. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Zimmer Biomet Holdings, Inc. dal 2000 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $933.60M | 12.37% |
| 2025 | $830.80M | -19.85% |
| 2024 | $1.04B | -2.88% |
| 2023 | $1.07B | 164.51% |
| 2022 | $403.50M | -19.14% |
| 2021 | $499.00M | -574.33% |
| 2020 | $-105.20M | -111.61% |
| 2019 | $905.80M | -434.12% |
| 2018 | $-271.10M | -158.35% |
| 2017 | $464.60M | 16.27% |
| 2016 | $399.60M | 160.84% |
| 2015 | $153.20M | -83.69% |
| 2014 | $939.40M | -4.25% |
| 2013 | $981.10M | -0.91% |
| 2012 | $990.10M | 1.14% |
| 2011 | $978.90M | 13.80% |
| 2010 | $860.20M | -13.82% |
| 2009 | $998.20M | -11.02% |
| 2008 | $1.12B | -0.87% |
| 2007 | $1.13B | -3.20% |
| 2006 | $1.17B | 12.33% |
| 2005 | $1.04B | 42.27% |
| 2004 | $731.50M | 67.20% |
| 2003 | $437.50M | 12.50% |
| 2002 | $388.90M | 61.44% |
| 2001 | $240.90M | -10.11% |
| 2000 | $268.00M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| $7.51B | 704.52% |
US
|
|
| $5.56B | 495.87% |
IE
|
|
| $5.15B | 451.41% |
US
|
|
| $3.86B | 313.56% |
US
|
|
| - | - |
DE
|
